Immediate Impact
2 by Nobel laureates 19 from Science/Nature 61 standout
Citing Papers
Renal cell carcinoma
2024 Standout
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
2023 Standout
Works of Teodoro Sava being referenced
First-Line PAzopanib in NOn–clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study
2016
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Teodoro Sava | 546 | 492 | 287 | 67 | 1.1k | |
| Sertaç Yazıcı | 368 | 485 | 452 | 54 | 1.1k | |
| Pasquale Rescigno | 748 | 306 | 368 | 82 | 1.2k | |
| Dingwei Ye | 597 | 398 | 486 | 83 | 1.1k | |
| Tomoaki Terakawa | 570 | 281 | 263 | 95 | 1.1k | |
| Nancy B. Davis | 361 | 460 | 290 | 59 | 947 | |
| Toshifumi Kurahashi | 467 | 270 | 227 | 50 | 855 | |
| Tatsuo Morita | 334 | 380 | 320 | 98 | 1.0k | |
| Junya Furukawa | 581 | 325 | 355 | 112 | 1.2k | |
| Michelle R. Downes | 645 | 378 | 382 | 75 | 1.3k | |
| R. Tarabuzzi | 807 | 456 | 237 | 41 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...